
Precision Medicine in Type 2 Diabetes: Targeting GLP1 Receptor Agonist and SGLT-2 Inhibitor Combination Treatment for Kidney Protection
The comprehensive study was presented on Monday, September 15th, 2025

The comprehensive study was presented on Monday, September 15th, 2025

A phase 1 clinical trial presented at the 61st European

A comprehensive analysis from the China Health and Retirement Longitudinal

A pioneering study has demonstrated that machine learning algorithms can

A new study from the University of Pisa has revealed

A groundbreaking French study has provided the first comprehensive evidence

Researchers have developed a groundbreaking artificial intelligence system called DiabetAid

A comprehensive analysis of over 74,000 patients with type 2

Italian researchers presented compelling evidence today at the 61st European

A comprehensive real-world study presented at the 61st European Association

A comprehensive analysis from the STEP UP trial presented at

A comprehensive analysis from the STEP UP trial presented at